Gansu Longshenrongfa Pharmaceutical Industry CO.,LTD (SHE:300534)
China flag China · Delayed Price · Currency is CNY
9.61
+0.11 (1.16%)
Apr 10, 2026, 1:55 PM CST

SHE:300534 Balance Sheet

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Cash & Equivalents
241.33289.65288.95369.2499.12
Cash & Short-Term Investments
241.33289.65288.95369.2499.12
Cash Growth
-16.68%0.24%-21.75%272.52%-16.13%
Accounts Receivable
257.51216.67223.8220.95140.44
Other Receivables
11.0619.2819.519.75.53
Receivables
268.57235.95243.3240.65145.98
Inventory
115.99115.8297.485.8755.7
Prepaid Expenses
-0.030.160.21.4
Other Current Assets
28.4135.0517.1931.576.51
Total Current Assets
654.3676.5647727.54308.7
Property, Plant & Equipment
531.64514.24439.42333.85305.21
Long-Term Investments
52.7551.3654.254.254.2
Goodwill
13.7213.7213.7213.7213.72
Other Intangible Assets
68.6562.8162.0762.2250.74
Long-Term Deferred Tax Assets
14.1311.510.128.585.77
Long-Term Deferred Charges
5.681.660.230.14-
Other Long-Term Assets
53.6270.51109.89117.2585.73
Total Assets
1,3941,4021,3371,318824.07
Accounts Payable
319.44361.08243.56209.0132.63
Accrued Expenses
8.0527.0823.1158.516.3
Short-Term Debt
0.25-30.03--
Current Portion of Long-Term Debt
50.3510.2---
Current Portion of Leases
-1.161.19--
Current Income Taxes Payable
18.8330.9121.117.481.78
Current Unearned Revenue
15.6222.465.6577.2412.96
Other Current Liabilities
45.266.5253.745.0814.64
Total Current Liabilities
457.74519.35438.34407.3268.32
Long-Term Debt
103.3595.84109.6--
Long-Term Leases
2.382.583.72--
Long-Term Unearned Revenue
46.931.3326.4426.8922.92
Long-Term Deferred Tax Liabilities
3.051.540.24-0
Other Long-Term Liabilities
-23.7546.8--
Total Liabilities
613.42674.39625.14434.2191.24
Common Stock
303.35303.35303.35303.35303.35
Additional Paid-In Capital
97.1583.8366.68324231.49
Retained Earnings
309.01277.35263.68202.03185.42
Comprehensive Income & Other
-1.05-2.24---
Total Common Equity
708.45662.28633.71829.38720.25
Minority Interest
72.6265.6477.853.9212.59
Shareholders' Equity
781.08727.93711.51883.3732.84
Total Liabilities & Equity
1,3941,4021,3371,318824.07
Total Debt
156.33109.78144.54--
Net Cash (Debt)
85179.88144.4369.2499.12
Net Cash Growth
-52.74%24.56%-60.89%272.52%105.97%
Net Cash Per Share
0.280.590.481.220.33
Filing Date Shares Outstanding
303.19303.35303.35303.35303.35
Total Common Shares Outstanding
303.19303.35303.35303.35303.35
Working Capital
196.56157.15208.65320.22240.38
Book Value Per Share
2.342.182.092.732.37
Tangible Book Value
626.08585.75557.91753.43655.78
Tangible Book Value Per Share
2.061.931.842.482.16
Buildings
-483.38339.21338.42283.91
Machinery
-198.76148.61125.1466.35
Construction In Progress
-27.61105.76.0937.76
Source: S&P Global Market Intelligence. Standard template. Financial Sources.